Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial.
- DOI
- 10.1111/cns.14010
- Published
- 2023 Jan
- Container
- CNS neuroscience & therapeutics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/cns.14010,
title = {Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial.},
author = {Abdallah MS and Mosalam EM and Hassan A and Ramadan AN and Omara-Reda H and Zidan AA and Samman WA and El-Berri EI},
year = {2023},
journal = {CNS neuroscience \& therapeutics},
doi = {10.1111/cns.14010},
url = {https://doi.org/10.1111/cns.14010}
}RIS
TY - JOUR TI - Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial. AU - Abdallah MS AU - Mosalam EM AU - Hassan A AU - Ramadan AN AU - Omara-Reda H AU - Zidan AA AU - Samman WA AU - El-Berri EI PY - 2023 JO - CNS neuroscience & therapeutics DO - 10.1111/cns.14010 UR - https://doi.org/10.1111/cns.14010 ER -
APA
MS, A., EM, M., A, H., AN, R., H, O., AA, Z., WA, S., & EI, E. (2023). Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double-blind, randomized, placebo-controlled trial.. CNS neuroscience & therapeutics. https://doi.org/10.1111/cns.14010
Source records
- pubmed · retrieved 2026-09-24T20:40:39.100Z